Daratumumab Or Darzalex Global Market Report 2025

Global Daratumumab Or Darzalex Market Report 2025

Daratumumab Or Darzalex Global Market Report 2025 – By Drug Type (100Mg Injection, 400Mg Injection), By Distribution Channel (Pharmacies, Hospital, Other Distribution Channels), By Application (Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Diffuse Large B Cell Lymphoma, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

Name: Daratumumab Or Darzalex Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Daratumumab Or Darzalex Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Daratumumab Or Darzalex Global Market Report 2025

Proud Members Of

Daratumumab Or Darzalex Market Definition

Daratumumab, or darzalex, refers to a monoclonal antibody used as a medication in the treatment of certain cancers, particularly multiple myelomas. It is designed to target and bind to CD38, a protein that is highly expressed on the surface of multiple myeloma cells, as well as other malignant and normal immune cells.

The main types of drugs in daratumumab or darzalex are 100 mg injection and 400 mg injection. A 100 mg injection refers to a dose of a medication or therapeutic substance that is administered via injection, containing 100 milligrams (mg) of the active ingredient. These drugs can be distributed through pharmacies, hospitals, and other distribution channels for various applications, such as Follicular Lymphoma, mantle cell lymphoma, multiple myeloma, diffuse large B cell lymphoma, and others.

Daratumumab Or Darzalex Market Segmentation

The daratumumab or darzalexmarket covered in this report is segmented –

1) By Drug Type: 100Mg Injection, 400Mg Injection

2) By Distribution Channel: Pharmacies, Hospital, Other Distribution Channels

3) By Application: Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Diffuse Large B Cell Lymphoma, Other Applications

Daratumumab Or Darzalex Market Size and growth rate 2025 to 2029: Graph

Daratumumab Or Darzalex Market Size 2025 And Growth Rate

The daratumumab or darzalex market size has grown rapidly in recent years. It will grow from $5,093.04 million in 2024 to $5,618.30 million in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to the adoption of multiple channels of research, increased feasibility of biomanufacturing operations, increased usage of monoclonal antibodies, increased number of strategic initiatives, and increased secretion of mAbs.

Daratumumab Or Darzalex Market Growth Forecast

The daratumumab or darzalex market size is expected to see rapid growth in the next few years. It will grow to $8,189.36 million in 2029 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing clinical evidence demonstrating, rising adoption in earlier treatment lines, increasing the demand for biologics, increasing patient awareness levels, growing incidence of blood cancer, and rising prevalence of chronic diseases. Major trends in the forecast period include technological advancements, new product launches, offerings of products and/or services, partnerships, mergers and acquisitions, advancements in radiation technologies, and collaborations.

Book your 30 minutes free consultation with our research experts

Daratumumab Or Darzalex Market Driver: Rising Incidence Of Bone Marrow Cancer Fuels Growth Of Daratumumab/Darzalex Market

The rise in incidence of bone marrow cancer is expected to propel the growth of the daratumumab or darzalex market going forward. Bone marrow cancer refers to cancers that begin in the bone marrow, such as multiple myeloma and leukemia, where abnormal blood cell production disrupts normal body function. The rising incidence of bone marrow cancers can be attributed to an aging population, improved detection methods, and contributing factors such as environmental influences, lifestyle choices, and genetic predispositions. Daratumumab (Darzalex) helps in the treatment of multiple myeloma, a type of bone marrow cancer, by targeting and destroying abnormal plasma cells in the bone marrow. For instance, in January 2024, according to the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, there were projected to be 89,190 lymphoma cases compared to 89,010 in 2022. Moreover, 35,780 cases of myeloma compared to 34,470 in 2022. Therefore, the rise in incidence of bone marrow cancer is driving the growth of the daratumumab or darzalex market.

Daratumumab Or Darzalex Market Driver: Rising Adoption Of Targeted Therapies And Biologics Driving Daratumumab Or Darzalex Market Growth

Rising adoption of biologics and targeted therapies is expected to propel the growth of the daratumumab or darzalex market going forward. Targeted therapies refer to a type of medical treatment that uses drugs or other substances to precisely identify and attack specific molecules involved in the growth and survival of cancer or other diseases. The adoption of biologics and targeted therapies is increasing due to the rising prevalence of chronic diseases and advancements in precision medicine, which enable more personalized, effective treatments. Daratumumab is utilized in targeted therapies due to its specific action on CD38, a protein highly expressed on the surface of malignant plasma cells in multiple myeloma. For instance, in December 2023, according to the Advanced Therapy Treatment Centers (ATTC), a UK-based network that works to bring new advanced therapy medicinal products (ATMPs) to patients, annual investments in advanced therapies rose by 31% in 2022, with the UK now accounting for 14% of all global commercial ATMP clinical trials. Therefore, rising adoption of biologics and targeted therapies is driving the growth of the daratumumab or darzalex market.

Global Daratumumab Or Darzalex Market Major Players

Major companies operating in the daratumumab or darzalex market include Genmab A/S, Janssen Biotech Inc.

Global Daratumumab Or Darzalex Market Trend: Focus On Transmembrane Proteins And Enhanced Treatment Solutions

The key trend in the daratumumab or darzalex market is focusing on a shift in oncology treatments towards early intervention solutions such as combination therapies to enhance efficacy in treating multiple myeloma and other cancers. Combination therapies refer to treatment strategies that use two or more therapeutic agents with different mechanisms of action, often synergistically, to enhance efficacy, minimize resistance, and improve patient outcomes while potentially reducing adverse effects compared to monotherapy. For instance, in July 2024, Johnson & Johnson, a US-based pharmaceutical industry company, received U.S. FDA approval for DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for induction and consolidation therapy in patients with newly diagnosed multiple myeloma (NDMM) eligible for autologous stem cell transplant (ASCT). This new approval provides a quadruplet therapy option at initial diagnosis, potentially improving patient outcomes.

Regional Outlook For The Global Daratumumab Or Darzalex Market

North America was the largest region in the daratumumab or darzalex market in 2024. The regions covered in the daratumumab or darzalex market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the daratumumab or darzalex market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Daratumumab Or Darzalex Market?

The daratumumab or darzalex market consists of sales of darzalex faspro, darzalex injection, dexamethasone, and pomalidomide. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Daratumumab Or Darzalex Industry?

The daratumumab or darzalex market research report is one of a series of new reports from The Business Research Company that provides daratumumab or darzalex market statistics, including daratumumab or darzalex industry global market size, regional shares, competitors with a daratumumab or darzalex market share, detailed daratumumab or darzalex market segments, market trends and opportunities, and any further data you may need to thrive in the daratumumab or darzalex industry. This daratumumab or darzalex market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Daratumumab Or Darzalex Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	CAGR of 10.0% from 2025 to 2034
Revenue Forecast In 2034	2024
Growth Rate	2019-2024
Base Year For Estimation	2025 - 2029 - 2034
Actual Estimates/Historical Data	Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period	1) By Drug Type: 100Mg Injection, 400Mg Injection 2) By Distribution Channel: Pharmacies, Hospital, Other Distribution Channels 3) By Application: Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Diffuse Large B Cell Lymphoma, Other Applications
Market Representation	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope	Genmab A/S, Janssen Biotech Inc.
Country Scope	Request for Sample
Key Companies Profiled	Explore Purchase Options
Customization Scope
Pricing And Purchase Options

1. Executive Summary

2. Daratumumab Or Darzalex Market Characteristics

3. Daratumumab Or Darzalex Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Daratumumab Or Darzalex Market Trends And Strategies

5. Daratumumab Or Darzalex Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Daratumumab Or Darzalex Growth Analysis And Strategic Analysis Framework

6.1. Global Daratumumab Or Darzalex PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Daratumumab Or Darzalex Market Growth Rate Analysis

6.4. Global Daratumumab Or Darzalex Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Daratumumab Or Darzalex Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Daratumumab Or Darzalex Total Addressable Market (TAM)

7. Global Daratumumab Or Darzalex Market Pricing Analysis & Forecasts

8. Daratumumab Or Darzalex Market Segmentation

8.1. Global Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

100Mg Injection

400Mg Injection

8.2. Global Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmacies

Hospital

Other Distribution Channels

8.3. Global Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Follicular Lymphoma

Mantle Cell Lymphoma

Multiple Myeloma

Diffuse Large B Cell Lymphoma

Other Applications

9. Global Daratumumab Or Darzalex Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Daratumumab Or Darzalex Market Regional And Country Analysis

10.1. Global Daratumumab Or Darzalex Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Daratumumab Or Darzalex Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Daratumumab Or Darzalex Market

11.1. Asia-Pacific Daratumumab Or Darzalex Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Daratumumab Or Darzalex Market

12.1. China Daratumumab Or Darzalex Market Overview

12.2. China Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Daratumumab Or Darzalex Market

13.1. India Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Daratumumab Or Darzalex Market

14.1. Japan Daratumumab Or Darzalex Market Overview

14.2. Japan Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Daratumumab Or Darzalex Market

15.1. Australia Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Daratumumab Or Darzalex Market

16.1. South Korea Daratumumab Or Darzalex Market Overview

16.2. South Korea Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Daratumumab Or Darzalex Market

17.1. Western Europe Daratumumab Or Darzalex Market Overview

17.2. Western Europe Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Daratumumab Or Darzalex Market

18.1. UK Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Daratumumab Or Darzalex Market

19.1. Germany Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Daratumumab Or Darzalex Market

20.1. France Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Daratumumab Or Darzalex Market

21.1. Eastern Europe Daratumumab Or Darzalex Market Overview

21.2. Eastern Europe Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Daratumumab Or Darzalex Market

22.1. North America Daratumumab Or Darzalex Market Overview

22.2. North America Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Daratumumab Or Darzalex Market

23.1. USA Daratumumab Or Darzalex Market Overview

23.2. USA Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Daratumumab Or Darzalex Market

24.1. Canada Daratumumab Or Darzalex Market Overview

24.2. Canada Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Daratumumab Or Darzalex Market

25.1. South America Daratumumab Or Darzalex Market Overview

25.2. South America Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Daratumumab Or Darzalex Market

26.1. Middle East Daratumumab Or Darzalex Market Overview

26.2. Middle East Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Daratumumab Or Darzalex Market

27.1. Africa Daratumumab Or Darzalex Market Overview

27.2. Africa Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Daratumumab Or Darzalex Market Competitive Landscape And Company Profiles

28.1. Daratumumab Or Darzalex Market Competitive Landscape

28.2. Daratumumab Or Darzalex Market Company Profiles

28.2.1. Genmab A/S Overview, Products and Services, Strategy and Financial Analysis

28.2.2. Janssen Biotech Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Daratumumab Or Darzalex Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Daratumumab Or Darzalex Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Daratumumab Or Darzalex Market

32. Recent Developments In The Daratumumab Or Darzalex Market

33. Daratumumab Or Darzalex Market High Potential Countries, Segments and Strategies

33.1 Daratumumab Or Darzalex Market In 2029 - Countries Offering Most New Opportunities

33.2 Daratumumab Or Darzalex Market In 2029 - Segments Offering Most New Opportunities

33.3 Daratumumab Or Darzalex Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Daratumumab Or Darzalex Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Daratumumab Or Darzalex Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Asia-Pacific, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Asia-Pacific, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: China, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: China, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: India, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: India, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Japan, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Japan, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Australia, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Australia, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: South Korea, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: South Korea, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: South Korea, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Western Europe, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Western Europe, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Western Europe, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: UK, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: UK, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: UK, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Germany, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Germany, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Germany, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: France, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: France, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: France, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Eastern Europe, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Eastern Europe, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Eastern Europe, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: North America, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: North America, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: North America, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: USA, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: USA, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: USA, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Canada, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Canada, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Canada, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: South America, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: South America, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: South America, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Middle East, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Middle East, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Middle East, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Africa, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Africa, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Africa, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Genmab A/S Financial Performance

Table 60: Janssen Biotech Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Daratumumab Or Darzalex Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Daratumumab Or Darzalex Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Asia-Pacific, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Asia-Pacific, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: China, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: China, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: India, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: India, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Japan, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Japan, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Australia, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Australia, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: South Korea, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: South Korea, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: South Korea, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Western Europe, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Western Europe, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Western Europe, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: UK, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: UK, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: UK, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Germany, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Germany, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Germany, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: France, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: France, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: France, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Eastern Europe, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Eastern Europe, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Eastern Europe, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: North America, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: North America, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: North America, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: USA, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: USA, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: USA, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Canada, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Canada, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Canada, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: South America, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: South America, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: South America, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Middle East, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Middle East, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Middle East, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Africa, Daratumumab Or Darzalex Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Africa, Daratumumab Or Darzalex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Africa, Daratumumab Or Darzalex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Genmab A/S Financial Performance

Figure 60: Janssen Biotech Inc. Financial Performance

What Is The Compression Therapy Market Overview In 2022?

Latest Contract Development Market Growth Study 2022-2026 By The Business Research Company

How Will The Fetal Bovine Serum Market Grow In 2022?

Latest Gynecology Drugs Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the anti-parkinson drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the autoimmune disease diagnosis market research report 2022 with industry size, share, segments and market growth

Antibody Contract Manufacturing Global Market Report 2025 – By Product (Monoclonal Antibodies, Polyclonal Antibodies, Other Products), By Source (Mammalian, Microbial, Scale Of Operation (Preclinical, Clinical, Commercial), By End-User (Biopharmaceutical Companies, Research Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Next-Generation Antibody Therapeutics Global Market Report 2025 – By Types Of Antibodies (Monoclonal Antibodies, Polyclonal Antibodies, Biospecific Antibodies, Antibody-Drug Conjugates, Other Types), By Therapeutic Area (Oncology, Autoimmune Diseases, Infectious Diseases, Neurodegenerative Disorders, Other Therapeutic Areas), By End-User (Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Antibody Drug Conjugates Global Market Report 2025 – By Type (Monoclonal Antibodies, Linker, Drug/Toxin, Other Types), By Product (Adcertis, Kadcyla, Other Products), By Technology (Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Other Technology), By Application (Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Other Applications), By End User (Hospital, Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Antibody Discovery Global Market Report 2025 – By Methods (Phage Display, Hybridoma, Other Methods), By Antibody Type (Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody), By End Users (Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Global Market Report 2025 – By Product (Cardiac Markers, Metabolic Markers, Renal Markers, Other Products), By Type (Goat, Rabbit, Horse, Mouse, Other Types), By Application (Enzyme Linked Immuno Absorbant Assay (ELISA), Immunoturbidimetry, Immunoelectrophoresis, Antibody Identification, Immunohistochemistry, Immunocytochemistry, Western Blotting), By End User (Pharmaceutical And Biotechnology Companies, Hospitals, Diagnostic Centers, Academic And Research Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Typhoid Antibody Testing Global Market Report 2025 – By Product Type (Rapid Serological Tests, Hem-agglutination And Co-agglutination, Counter Immunoelectrophoresis, Typhidot Test, Widal Test), By Paratyphi Type (Paratyphi A, Paratyphi B, Paratyphi C), By End-User (Hospitals, Serological Testing Centers, Clinics, Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Antibody Drug Conjugates Contract Manufacturing Global Market Report 2025 – By Type (Immunoglobulin G1 (Igg–, Immunoglobulin G4 (Igg,), By Linker (Cleavable Linker, Non-Cleavable Linker), By Condition (Myeloma, Lymphoma, Breast Cancer, Other Conditions), By Phase (Clinical, Commercial) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmacovigilance And Drug Safety Software Global Market Report 2025 – By Software Type (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software), By Delivery Mode (On-premise, Cloud-based), By End User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Daratumumab Or Darzalex market?

How will the Daratumumab Or Darzalex market drivers and restraints affect the market dynamics? What forces will shape the Daratumumab Or Darzalex industry going forward?

The Daratumumab Or Darzalex market major growth driver - Rising Incidence Of Bone Marrow Cancer Fuels Growth Of Daratumumab/Darzalex Market. For further insights on the Daratumumab Or Darzalex market, request a sample here

What is the forecast market size or the forecast market value of the Daratumumab Or Darzalex market?

The Daratumumab Or Darzalex market size has grown strongly in recent years. The daratumumab or darzalex market size has grown rapidly in recent years. It will grow from $5,093.04 million in 2024 to $5,618.30 million in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to the adoption of multiple channels of research, increased feasibility of biomanufacturing operations, increased usage of monoclonal antibodies, increased number of strategic initiatives, and increased secretion of mAbs. The daratumumab or darzalex market size is expected to see rapid growth in the next few years. It will grow to $8,189.36 million in 2029 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing clinical evidence demonstrating, rising adoption in earlier treatment lines, increasing the demand for biologics, increasing patient awareness levels, growing incidence of blood cancer, and rising prevalence of chronic diseases. Major trends in the forecast period include technological advancements, new product launches, offerings of products and/or services, partnerships, mergers and acquisitions, advancements in radiation technologies, and collaborations. For further insights on the Daratumumab Or Darzalex market, request a sample here

How is the Daratumumab Or Darzalex market segmented?

The daratumumab or darzalexmarket covered in this report is segmented –
1) By Drug Type: 100Mg Injection; 400Mg Injection
2) By Distribution Channel: Pharmacies; Hospital; Other Distribution Channels
3) By Application: Follicular Lymphoma; Mantle Cell Lymphoma; Multiple Myeloma; Diffuse Large B Cell Lymphoma; Other Applications For further insights on the Daratumumab Or Darzalex market, request a sample here

Which region has the largest share of the Daratumumab Or Darzalex market? What are the other regions covered in the report?

Who are the major players in the Daratumumab Or Darzalex market?

Major companies operating in the daratumumab or darzalex market include Genmab A/S, Janssen Biotech Inc. . For further insights on the Daratumumab Or Darzalex market, request a sample here.

What are the key trends in the Daratumumab Or Darzalex market?

Major trends in the Daratumumab Or Darzalex market include Focus On Transmembrane Proteins And Enhanced Treatment Solutions. For further insights on the Daratumumab Or Darzalex market, request a sample here.

What are the major opportunities in the Daratumumab Or Darzalex market? What are the strategies for the Daratumumab Or Darzalex market?

For detailed insights on the major opportunities and strategies in the Daratumumab Or Darzalex market, request a sample here.

How does the Daratumumab Or Darzalex market relate to the overall economy and other similar markets?

For detailed insights on Daratumumab Or Darzalex's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Daratumumab Or Darzalex industry?

For detailed insights on the mergers and acquisitions in the Daratumumab Or Darzalex industry, request a sample here.

What are the key dynamics influencing the Daratumumab Or Darzalex market growth? SWOT analysis of the Daratumumab Or Darzalex market.

For detailed insights on the key dynamics influencing the Daratumumab Or Darzalex market growth and SWOT analysis of the Daratumumab Or Darzalex industry, request a sample here.